Host cell-type and pathogen-specific immunomodulatory functions of macrophage migration inhibitory factor (MIF) in infectious keratitis.

Acanthamoeba castellanii Aspergillus flavus Corneal infection Immunomodulation Infectious keratitis Inflammatory response Macrophage migration inhibitory factor

Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
11 2023
Historique:
received: 27 05 2023
revised: 11 09 2023
accepted: 27 09 2023
medline: 13 11 2023
pubmed: 30 9 2023
entrez: 29 9 2023
Statut: ppublish

Résumé

Therapeutic management of inflammation in infectious keratitis (IK) requires new strategy and targets for selective immunomodulation. Targeting host cell-type specific inflammatory responses might be a viable strategy to curtail unnecessary inflammation and reduce tissue damage without affecting pathogen clearance. This study explores the possibility of pathogen and host cell-type dependent differences in the inflammatory pathways relevant in the pathogenesis of IK. Human corneal epithelial cell line (HCEC) and phorbol 12-myristate-13 acetate (PMA) differentiated THP-1 macrophage line were infected with either Aspergillus flavus conidia or Acanthamoeba castellanii trophozoites and the elicited inflammatory responses were studied in terms of gene expression and secretion of proinflammatory factors interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α) and an upstream inflammatory regulator and mediator protein-the Macrophage Migration Inhibitory Factor (MIF). Given the pleotropic mode of MIF function in diverse cell types relevant in many human diseases, we tested if MIF driven responses to infection is different in HCECs and THP-1 macrophages by studying its expression, secretion and involvement in inflammation by siRNA mediated knockdown. We also examined IK patient tear samples for MIF levels. Infection with A. flavus or A. castellanii induced IL-8 and TNF-α responses in HCECs and THP-1 macrophages but to different levels. Our preliminary human data showed that the level of secreted MIF protein was elevated in IK patient tear, however, MIF secretion by the two cell types were strikingly different in-vitro, under both normal and infected conditions. We found that HCECs released MIF constitutively, which was significantly inhibited with infection, whereas THP-1 macrophages were stimulated to release MIF during infection. MIF gene expression remained largely unaffected by infection in both the cell lines. Although MIF in HCECs appeared to be intracellularly captured during infection, MIF knockdown in HCECs associated with a partial reduction of the IL-8 and TNF-α expression produced by either of the pathogens, suggesting a pro-inflammatory role for MIF in HCECs, independent of its canonical cytokine like function. In contrast, MIF knockdown in THP-1 macrophages accompanied a dramatic increase in IL-8 and TNF-α expression during A. castellanii infection, while the responses to A. flavus infection remained unchanged. These data imply a host cell-type and pathogen specific distinction in the MIF- related inflammatory signaling and MIF as a potential selective immunomodulatory target in infectious keratitis.

Identifiants

pubmed: 37774962
pii: S0014-4835(23)00290-7
doi: 10.1016/j.exer.2023.109669
pii:
doi:

Substances chimiques

Macrophage Migration-Inhibitory Factors 0
Tumor Necrosis Factor-alpha 0
Interleukin-8 0
MIF protein, human EC 5.3.2.1
Intramolecular Oxidoreductases EC 5.3.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109669

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests.

Auteurs

Swagata Ghosh (S)

Department of Microbiology, Aravind Medical Research Foundation, Madurai, India. Electronic address: swagata@aravind.org.

A H Humera Khathun (AH)

Department of Microbiology, Aravind Medical Research Foundation, Madurai, India.

G S Athulya (GS)

Department of Microbiology, Aravind Medical Research Foundation, Madurai, India.

P Vignesh (P)

Department of Microbiology, Aravind Medical Research Foundation, Madurai, India.

L Mathan (L)

Department of Proteomics, Aravind Medical Research Foundation, Madurai, India.

Ninad Mudaraddi (N)

Department of Cornea and Refractive Surgery, Aravind Eye Hospital, Madurai, India.

Siddharth Narendran (S)

Department of Microbiology, Aravind Medical Research Foundation, Madurai, India; Aravind Eye Hospital, Coimbatore, India.

Prajna Lalitha (P)

Department of Ocular Microbiology, Aravind Eye Hospital, Madurai, India.

N Venkatesh Prajna (N)

Department of Cornea and Refractive Surgery, Aravind Eye Hospital, Madurai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH